Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kinesin light chain 4 (KLC4) is a subunit of the kinesin-1 motor protein complex and plays a critical role in microtubule-based transport within cells. KLC4 functions as a cargo adaptor, specifying which cellular cargoes are transported by the kinesin-1 motor along microtubules, particularly in neurons. It is essential for the development of proper neuronal morphology, axon branching, and compartmentalization, as well as for behaviors associated with sensory response and stress in model organisms. Mutations in KLC4 have been linked to a spectrum of neurodevelopmental and neurodegenerative disorders, such as hereditary spastic paraplegia, retinitis pigmentosa, sensorineural hearing loss, and demyelinating neuropathy. While not recognized as a classic drug target or receptor, research compounds such as Kinesore can modulate KLC4 function to explore its cellular roles[1][2][3][4].
Disrupts KLC-cargo adaptor interactions and modulates kinesin-mediated microtubule dynamics[2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kinesin light chain 4 (KLC4).